Skip to main content
Erschienen in: Supportive Care in Cancer 9/2014

01.09.2014 | Original Article

The association of presurgery psychological symptoms with postsurgery pain among cancer patients receiving implantable devices for pain management

verfasst von: Carrie J. Aigner, Mike Hernandez, Lakshmi Koyyalagunta, Diane Novy

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Psychological symptoms are a common part of the cancer pain experience, yet little is known about how these factors relate to implantable device outcomes in patients with cancer pain. The purpose of this study was to examine how psychological symptoms relate to implantable device outcomes in cancer pain management.

Methods

We retrospectively examined the medical records of 79 cancer patients, collecting information on psychological symptoms and pain, as assessed on the Edmonton Symptom Assessment System. Data were collected prior to and at three points following the implantation of either a spinal cord stimulator or an intrathecal pump.

Results

Pain was correlated with both anxiety, r = 0.39 (n = 74, p < 0.01), and depression, r = 0.38, (n = 75, p < 0.01), at the presurgery baseline. Results of linear mixed model (LMM) analysis indicated that neither baseline anxiety nor baseline depression main effects were significantly associated with pain at postimplant assessments, when adjusting for baseline pain, demographics, and clinical factors. However, the group-by-time interaction was significant for anxiety (beta = 0.223, p value = 0.037). The trajectory of pain scores over time differed by baseline anxiety scores, with pain scores increasing over time at a higher rate for those with a high baseline anxiety score, compared to those with low baseline anxiety scores.

Conclusion

Presurgery psychological symptoms should be considered, along with other medical, psychosocial, and individual characteristics in multidisciplinary treatment planning. Multidisciplinary care which includes aspects of mood management or supportive psychotherapy would likely be beneficial to cancer patients presenting with high psychological symptoms.
Literatur
1.
Zurück zum Zitat Deer TS, Smith HS, Burton A, Pope J, Doleys D, Levy R, Staats P, Wallace M, Webster L (2011) Comprehensive consensus based guildelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Physician 14:E283–E312PubMed Deer TS, Smith HS, Burton A, Pope J, Doleys D, Levy R, Staats P, Wallace M, Webster L (2011) Comprehensive consensus based guildelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Physician 14:E283–E312PubMed
2.
Zurück zum Zitat Stojanovic M, Abdi S (2002) Spinal cord stimulatin. Pain Physician 5(2):156–166PubMed Stojanovic M, Abdi S (2002) Spinal cord stimulatin. Pain Physician 5(2):156–166PubMed
3.
Zurück zum Zitat Burchiel K, Anderson V, Brown F, Fessler R (1996) Prospective multicenter study of spinal cord stimulation for relief of chronic back and extremity pain. Spine 23:2786–2794CrossRef Burchiel K, Anderson V, Brown F, Fessler R (1996) Prospective multicenter study of spinal cord stimulation for relief of chronic back and extremity pain. Spine 23:2786–2794CrossRef
4.
Zurück zum Zitat Bennett G, Serafini M, Burchiel K, Buchser E, Classen A, Deer T, Du Pen S, Ferrante M (2000) Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manag 20(2):S12–S35CrossRef Bennett G, Serafini M, Burchiel K, Buchser E, Classen A, Deer T, Du Pen S, Ferrante M (2000) Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manag 20(2):S12–S35CrossRef
5.
Zurück zum Zitat Middel B, Kuipers-Upmeijer H, Bouma J, Stall M (1997) Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatry 63:204–209PubMedCentralPubMedCrossRef Middel B, Kuipers-Upmeijer H, Bouma J, Stall M (1997) Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatry 63:204–209PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Syrjala K, Chapko M (1995) Evidence for a biopsychosocial model of cancer treatment-related pain. Pain 61:69–79PubMedCrossRef Syrjala K, Chapko M (1995) Evidence for a biopsychosocial model of cancer treatment-related pain. Pain 61:69–79PubMedCrossRef
7.
Zurück zum Zitat Burchiel K, Anderson V, Wilson BJ, Denison D, Olson K, Shatin D (1995) Prognostic factors of spinal cord stimulation for chronic back and leg pain. Neurosurgery 36:1101–1111PubMedCrossRef Burchiel K, Anderson V, Wilson BJ, Denison D, Olson K, Shatin D (1995) Prognostic factors of spinal cord stimulation for chronic back and leg pain. Neurosurgery 36:1101–1111PubMedCrossRef
8.
Zurück zum Zitat Olson K, Bedder M, Anderson V, Burchiel K, Villanueva M (1995) Psychological variables associated with outcome in spinal cord stimulation trials. Clin J Pain 17:155–161 Olson K, Bedder M, Anderson V, Burchiel K, Villanueva M (1995) Psychological variables associated with outcome in spinal cord stimulation trials. Clin J Pain 17:155–161
9.
Zurück zum Zitat Heckler D, Gatchel R, Lou L, Whitworth T, Bernstein D, Stowell A (2007) Presurgical behavioral medicine evaluation (PBME) for implantable devices for pain management: a 1-year prospective study. Pain Pract 7(2):110–122PubMedCrossRef Heckler D, Gatchel R, Lou L, Whitworth T, Bernstein D, Stowell A (2007) Presurgical behavioral medicine evaluation (PBME) for implantable devices for pain management: a 1-year prospective study. Pain Pract 7(2):110–122PubMedCrossRef
10.
Zurück zum Zitat Prager J, Jacobs M (2001) Evaluation of patients for implantable pain modalities: medical and behavioral assessment. Clin J Pain 17:206–214PubMedCrossRef Prager J, Jacobs M (2001) Evaluation of patients for implantable pain modalities: medical and behavioral assessment. Clin J Pain 17:206–214PubMedCrossRef
11.
Zurück zum Zitat Deer T, Smith H, Cousins M, Doleys D, Levy R, Rathmell J, Staats P (2010) Consensus guidelines for the selection and implantation of patients with noncancer pain for intratecal drug delivery. Pain Physician 13:E175–E213PubMed Deer T, Smith H, Cousins M, Doleys D, Levy R, Rathmell J, Staats P (2010) Consensus guidelines for the selection and implantation of patients with noncancer pain for intratecal drug delivery. Pain Physician 13:E175–E213PubMed
12.
Zurück zum Zitat Nelson D, Kennington M, Novy D, Squitieri P (1996) Psychosocial selection criteria for implantable spinal cord stimulators. Pain Forum 52(2):93–103CrossRef Nelson D, Kennington M, Novy D, Squitieri P (1996) Psychosocial selection criteria for implantable spinal cord stimulators. Pain Forum 52(2):93–103CrossRef
13.
Zurück zum Zitat Beltrutti D, Lamberto A, Barolat G, Bruehl S, Doleys D, Krames E, Meglio M, North R, Olson K, Reig E, Melzack R (2004) The psychological assessments of candidates for spinal cord stimulation for chronic pain management. Pain Pract 4(3):204–221PubMedCrossRef Beltrutti D, Lamberto A, Barolat G, Bruehl S, Doleys D, Krames E, Meglio M, North R, Olson K, Reig E, Melzack R (2004) The psychological assessments of candidates for spinal cord stimulation for chronic pain management. Pain Pract 4(3):204–221PubMedCrossRef
14.
Zurück zum Zitat Lechnyr T (2009) Pre-implant psychological evaluations. Practical Pain Management (January/February) Lechnyr T (2009) Pre-implant psychological evaluations. Practical Pain Management (January/February)
15.
Zurück zum Zitat Ahmed S, Martin N, Chang Y (2005) Patient selection and trial methods for intraspinal drug delivery for chronic pain: a national survey. Neuromodulation 8(2):112–120PubMedCrossRef Ahmed S, Martin N, Chang Y (2005) Patient selection and trial methods for intraspinal drug delivery for chronic pain: a national survey. Neuromodulation 8(2):112–120PubMedCrossRef
16.
Zurück zum Zitat Sellick S, Crooks D (1999) Depression and cancer: an appraisal of the literature for prevalence, detection, and practice guideline development for psychosocial interventions. Psycho-Oncology 8:315–333PubMedCrossRef Sellick S, Crooks D (1999) Depression and cancer: an appraisal of the literature for prevalence, detection, and practice guideline development for psychosocial interventions. Psycho-Oncology 8:315–333PubMedCrossRef
17.
Zurück zum Zitat Delgado-Guay M, Parson H, Li Z, Palmer J, Bruera E (2009) Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer 17:573–579PubMedCrossRef Delgado-Guay M, Parson H, Li Z, Palmer J, Bruera E (2009) Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer 17:573–579PubMedCrossRef
18.
Zurück zum Zitat Gao W, Bennett M, Stark D, Murray S, Higginson I (2010) Psychological distress in cancer from survivorship to end of life care: prevalence, associated factors and clinical implications. Eur J Cancer 46(11):2036–2044PubMedCrossRef Gao W, Bennett M, Stark D, Murray S, Higginson I (2010) Psychological distress in cancer from survivorship to end of life care: prevalence, associated factors and clinical implications. Eur J Cancer 46(11):2036–2044PubMedCrossRef
19.
Zurück zum Zitat Chang V, Shirley H, Feuerman M (2000) Validation of the Edmonton Symptom Assessment Scale. Cancer 88(9):2164–2171PubMedCrossRef Chang V, Shirley H, Feuerman M (2000) Validation of the Edmonton Symptom Assessment Scale. Cancer 88(9):2164–2171PubMedCrossRef
20.
Zurück zum Zitat Jensen M (2003) The validity and reliability of pain measures in adults with cancer. J Pain 4(1):2–21PubMedCrossRef Jensen M (2003) The validity and reliability of pain measures in adults with cancer. J Pain 4(1):2–21PubMedCrossRef
21.
Zurück zum Zitat Holen J, Lydersen S, Klepstad P, Loge J, Kaasa S (2008) The Brief Pain Inventory: pain’s interference with functions is different in cancer pain compared with noncancer chronic pain. Clin J Pain 24:219–225PubMedCrossRef Holen J, Lydersen S, Klepstad P, Loge J, Kaasa S (2008) The Brief Pain Inventory: pain’s interference with functions is different in cancer pain compared with noncancer chronic pain. Clin J Pain 24:219–225PubMedCrossRef
22.
Zurück zum Zitat Cleeland C (2009) The Brief Pain Inventory user guide. MD Anderson Cancer Center, Houston Cleeland C (2009) The Brief Pain Inventory user guide. MD Anderson Cancer Center, Houston
23.
Zurück zum Zitat Fitzgerald P, Lo C, Li M, Gagliese L, Zimmerman C, Rodin G (2013) The relationship between depression and physical symptom burden in advanced cancer. BMJ Supportive and Palliative Care 0:1–8 Fitzgerald P, Lo C, Li M, Gagliese L, Zimmerman C, Rodin G (2013) The relationship between depression and physical symptom burden in advanced cancer. BMJ Supportive and Palliative Care 0:1–8
24.
Zurück zum Zitat Galloway S, Baker M, Giglio P, Chin S, Madan A, Malcolm R, Serber E, Wedin S, Balliet W, Borckardt J (2012) Depression and anxiety symptoms relate to distinct components of pain experience among patients with breast cancer. Pain Res Treat 2012:1–4CrossRef Galloway S, Baker M, Giglio P, Chin S, Madan A, Malcolm R, Serber E, Wedin S, Balliet W, Borckardt J (2012) Depression and anxiety symptoms relate to distinct components of pain experience among patients with breast cancer. Pain Res Treat 2012:1–4CrossRef
25.
Zurück zum Zitat Zoega S, Fridriksdottir N, Sigurdardottir V, Gunnarsdottir S (2013) Pain and other symtoms and their relationship to quality of life in cancer patients on opioids. Qual Life Res 22:1273–1280PubMedCrossRef Zoega S, Fridriksdottir N, Sigurdardottir V, Gunnarsdottir S (2013) Pain and other symtoms and their relationship to quality of life in cancer patients on opioids. Qual Life Res 22:1273–1280PubMedCrossRef
26.
Zurück zum Zitat Molloy AN, Nicholas MK, Asghari A, Beeston L, Dehghani M, Cousins M, Brooker C, Tonkin L (2006) Does a combination of intensive cognitive-behavioral pain management and a spinal implantable device confer any advantage? A preliminary examination. Pain Pract 6(2):96–103PubMedCrossRef Molloy AN, Nicholas MK, Asghari A, Beeston L, Dehghani M, Cousins M, Brooker C, Tonkin L (2006) Does a combination of intensive cognitive-behavioral pain management and a spinal implantable device confer any advantage? A preliminary examination. Pain Pract 6(2):96–103PubMedCrossRef
Metadaten
Titel
The association of presurgery psychological symptoms with postsurgery pain among cancer patients receiving implantable devices for pain management
verfasst von
Carrie J. Aigner
Mike Hernandez
Lakshmi Koyyalagunta
Diane Novy
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2219-y

Weitere Artikel der Ausgabe 9/2014

Supportive Care in Cancer 9/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.